Insider Transactions in Q2 2023 at Therapeutics Md, Inc. (TXMD)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2023
|
Rubric Capital Management LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
312,525
+13.12%
|
$937,575
$3.68 P/Share
|
Apr 12
2023
|
Marlan D Walker Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,170
-8.68%
|
$3,510
$3.65 P/Share
|
Apr 12
2023
|
Marlan D Walker Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,508
+14.66%
|
-
|
Apr 12
2023
|
Michael C Donegan Prin. Fin. and Acctg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+44.7%
|
-
|